1.2 Preoperative Diagnostic Testing, Coagulation Panels & Critical Lab Values
Key Takeaways
- Preoperative targeted laboratory testing is dictated by patient comorbidities and surgical risk, replacing non-selective blanket screening.
- An elective surgical cutoff for Prothrombin Time / INR is typically ≤ 1.5; patients on warfarin require discontinuation 5 days prior to surgery, with bridging anticoagulation if thromboembolic risk is elevated.
- Critical surgical platelet thresholds are < 50,000 /µL for major elective surgery and < 100,000 /µL for neurosurgical or ophthalmic procedures.
- Preoperative serum potassium levels < 3.0 mEq/L or > 5.5 mEq/L represent critical cancellation thresholds due to the risk of lethal intraoperative cardiac dysrhythmias.
- Glycemic control must maintain perioperative blood glucose between 140 and 180 mg/dL; values exceeding 180 mg/dL significantly increase surgical site infection (SSI) rates and delay wound healing.
Preoperative Diagnostic Testing, Coagulation Panels & Critical Lab Values
Modern perioperative practice has shifted away from routine, blanket preoperative testing toward targeted, evidence-based diagnostic evaluation. Routine diagnostic testing in asymptomatic, healthy patients undergoing low-risk surgery yields low diagnostic returns, increases healthcare costs, and leads to unnecessary delays. Preoperative lab tests and diagnostic studies must be ordered based on patient age, underlying comorbidities, specific drug therapies, and the invasiveness of the planned surgical procedure.
Coagulation Panels & Hemostatic Evaluation
Assessment of the hemostatic mechanism is vital for procedures with high expected blood loss or operations in closed anatomical spaces (e.g., neurosurgery, spinal surgery, ophthalmic procedures).
Key Coagulation Tests & Clinical Parameters
| Test | Reference Range | Surgical Threshold / Target | Clinical Management & Reversal |
|---|---|---|---|
| PT / INR | PT: 11.0–13.5 s<br>INR: 0.8–1.2 | Elective Surgery Cutoff:<br>INR ≤ 1.5<br>(Mechanical valves: 2.5–3.5) | Warfarin: Discontinue 5 days preop. Bridge with LMWH (enoxaparin) for high VTE risk.<br>Reversal: Vitamin K (phytonadione), 4F-PCC (Kcentra), or FFP. |
| aPTT | 25.0–35.0 s | Baseline required for heparin therapy;<br>Target 1.5–2.5x control | Unfractionated Heparin (UFH): Hold IV infusion 4–6 hours preop.<br>Reversal: Protamine sulfate (1 mg per 100 units UFH). |
| Platelets | 150,000–450,000 /µL | Major Surgery: ≥ 50,000 /µL<br>Neurosurgery/Eye: ≥ 100,000 /µL<br>Spontaneous Bleed: < 20,000 /µL | Transfuse pooled random-donor platelets or single-donor apheresis units for counts below surgical threshold. |
| Fibrinogen | 200–400 mg/dL | Critical Threshold:<br>< 100–150 mg/dL | Administer Cryoprecipitate (10-unit pool increases fibrinogen by ~50 mg/dL) or fibrinogen concentrate. |
- Prothrombin Time (PT) & International Normalized Ratio (INR): Evaluates the extrinsic and common coagulation pathways (Factors I, II, V, VII, X). Patients taking oral vitamin K antagonists (warfarin) must discontinue therapy 5 days prior to elective surgery to allow INR to normalize to ≤ 1.5. If urgent surgical reversal is required, Four-Factor Prothrombin Complex Concentrate (4F-PCC / Kcentra) is preferred over Fresh Frozen Plasma (FFP) because it achieves rapid INR reduction without volume overload.
- Activated Partial Thromboplastin Time (aPTT): Measures the intrinsic and common pathways (Factors VIII, IX, XI, XII, I, II, V, X). IV unfractionated heparin (UFH) has a short half-life (1 to 2 hours) and should be discontinued 4 to 6 hours prior to surgery. Protamine sulfate reverses UFH (1 mg protamine neutralizes approximately 100 units of UFH).
- Platelet Function & Count: Patients taking antiplatelet agents (e.g., clopidogrel, prasugrel, ticagrelor) require discontinuation 5 to 7 days prior to elective procedures to restore platelet aggregation. Aspirin may be continued in patients with recent drug-eluting coronary stents unless undergoing intracranial or intraocular surgery.
Electrolytes & Critical Metabolic Cutoffs
Electrolyte derangements alter cardiac conduction, myocardial contractility, neuromuscular responsiveness, and vascular tone under general and regional anesthesia.
1. Potassium (K+) — Reference Range: 3.5–5.0 mEq/L
- Hypokalemia (< 3.5 mEq/L): Hypokalemia sensitizes the myocardium to digitalis toxicity and increases intraoperative ventricular dysrhythmias (ventricular ectopy, VT/VF), particularly in the presence of volatile anesthetics. On ECG, hypokalemia manifests as flattened T waves, ST depression, and prominent U waves. Elective surgery should be postponed if serum potassium is < 3.0 mEq/L.
- Hyperkalemia (> 5.5 mEq/L): Hyperkalemia impairs cardiac conduction, progressing on ECG from tall peaked T waves to PR prolongation, QRS widening, sine wave patterns, and cardiac arrest. Elective surgery is cancelled for potassium levels > 5.5 mEq/L. Emergency treatment includes IV calcium chloride/gluconate (myocardial membrane stabilization), IV regular insulin (10 units) with 50% Dextrose (intracellular K+ shift), sodium bicarbonate, and loop diuretics or sodium zirconium cyclosilicate.
2. Sodium (Na+) — Reference Range: 135–145 mEq/L
- Hyponatremia (< 135 mEq/L): Severe hyponatremia (< 120 mEq/L) causes cerebral edema, agitation, seizures, and coma. A classic perioperative etiology is Fluid Absorption Syndrome occurring during transurethral resection of the prostate (TURP) or hysteroscopic surgery, caused by systemic absorption of non-conductive irrigation fluid (glycine, sorbitol). Rapid correction of chronic hyponatremia must be avoided to prevent Central Pontine Myelinolysis (Osmotic Demyelination Syndrome); correction rate must not exceed 8 to 10 mEq/L per 24 hours.
3. Renal Function — Creatinine (0.6–1.2 mg/dL) & BUN (7–20 mg/dL)
- Preoperative serum creatinine > 2.0 mg/dL (177 µmol/L) is a major independent predictor of adverse cardiac events (included in the Revised Cardiac Risk Index). Renal insufficiency impairs clearance of neuromuscular blocking agents (e.g., rocuronium, pancuronium) and hydrophilic opioids (morphine, hydromorphone). For patients with ESRD, cisatracurium is the neuromuscular blocker of choice because it undergoes Hofmann elimination (spontaneous ester hydrolysis independent of renal/hepatic function).
Hematology & Glycemic Parameters
Complete Blood Count (CBC) & Transfusion Cutoffs
- Hemoglobin (Hgb) / Hematocrit (Hct): Normal Hgb is 12.0–16.0 g/dL in females and 14.0–18.0 g/dL in males. According to AABB guidelines, a restrictive transfusion threshold of Hgb < 7.0 g/dL is standard for hemodynamically stable adult surgical patients, targeting a post-transfusion Hgb of 7.0 to 8.0 g/dL. In patients with active coronary artery disease or symptomatic anemia, a higher threshold of Hgb < 8.0 g/dL is maintained.
Glycemic Management
- Blood Glucose Target: Perioperative blood glucose must be maintained between 140 and 180 mg/dL (7.8–10.0 mmol/L). Hyperglycemia exceeding 180 mg/dL impairs neutrophil phagocytosis, increases Surgical Site Infection (SSI) rates, induces osmotic diuresis, and delays wound healing. Hemoglobin A1c (HbA1c) testing should be reviewed; an HbA1c > 8.0% indicates chronic poor glycemic control requiring perioperative endocrine management.
Pregnancy Testing Protocol
Serum or urine human chorionic gonadotropin (hCG) screening is mandatory for all female patients of childbearing potential (from menarche to menopause) on the day of surgery prior to administering anesthetic agents, due to the potential teratogenic effects of anesthetic drugs and risks to fetal organogenesis.
Exam Traps & Clinical Pitfalls
- Exam Trap: Memorizing old 10% cross-reactivity stats. Understand modern targeted lab guidelines—do not assume every patient needs a routine CBC, BMP, and PT/INR unless clinically indicated by history or surgical complexity.
- Clinical Pitfall: Administering neuromuscular blockers to a patient with renal failure without verifying the drug's elimination path. Always select cisatracurium or atracurium (Hofmann elimination) for patients with creatinine > 2.0 mg/dL or ESRD.
A 67-year-old female with atrial fibrillation managed with warfarin (Coumadin) is scheduled for an elective total knee arthroplasty. The patient stopped taking her warfarin 5 days prior to surgery per instructions. Her preoperative lab results are: PT 18.2 seconds, INR 2.4, Platelets 210,000 /µL, Serum Creatinine 0.9 mg/dL. Which nursing action is most appropriate?
A perioperative nurse reviews morning laboratory results for a 72-year-old patient undergoing an elective colectomy. The patient's serum potassium level is reported as 2.7 mEq/L. The ECG monitor shows sinus rhythm with flattened T waves and prominent U waves. What is the priority nursing intervention?
A patient with severe end-stage renal disease (ESRD) on hemodialysis and a baseline serum creatinine of 4.8 mg/dL is scheduled for emergency laparotomy. The anesthesia provider plans to administer a neuromuscular blocking agent for endotracheal intubation and abdominal relaxation. Which neuromuscular blocker is safest for this patient?